Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$2.59 USD
+0.01 (0.39%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $2.60 +0.01 (0.39%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for Aveanna Healthcare Holdings Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,895 | 1,788 | 1,679 | 1,495 | 1,384 |
Cost Of Goods | 1,300 | 1,234 | 1,136 | 1,041 | 965 |
Gross Profit | 595 | 553 | 542 | 455 | 419 |
Selling & Adminstrative & Depr. & Amort Expenses | 587 | 1,196 | 579 | 458 | 380 |
Income After Depreciation & Amortization | 8 | -642 | -36 | -3 | 39 |
Non-Operating Income | 6 | 86 | -9 | 35 | -22 |
Interest Expense | 153 | 108 | 69 | 83 | 92 |
Pretax Income | -139 | -664 | -114 | -52 | -75 |
Income Taxes | -4 | -2 | 3 | 5 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -135 | -662 | -117 | -57 | -77 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -135 | -662 | -117 | -57 | -77 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 148 | 80 | 126 | 110 | 73 |
Depreciation & Amortization (Cash Flow) | 140 | 722 | 162 | 113 | 34 |
Income After Depreciation & Amortization | 8 | -642 | -36 | -3 | 39 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 189.96 | 185.55 | 170.63 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.16 | -0.08 | 0.42 | NA | NA |
Diluted Net EPS (GAAP) | -0.71 | -3.57 | -0.69 | NA | NA |
Fiscal Year end for Aveanna Healthcare Holdings Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 490.65 | 478.84 | 478.01 | 471.95 | 466.41 |
Cost Of Goods | 344.80 | 330.39 | 330.75 | 316.69 | 321.95 |
Gross Profit | 145.85 | 148.45 | 147.26 | 155.26 | 144.47 |
SG&A, R&D, and Dept/Amort Expenses | 122.99 | 119.15 | 223.62 | 117.76 | 126.83 |
Income After SG&A, R&D, and Dept/Amort Expenses | 22.86 | 29.30 | -76.36 | 37.50 | 17.64 |
Non-Operating Income | 18.27 | -21.18 | 14.19 | 25.28 | -12.11 |
Interest Expense | 39.65 | 39.70 | 39.60 | 37.99 | 35.96 |
Pretax Income | 1.49 | -31.60 | -101.76 | 24.79 | -30.43 |
Income Taxes | 12.66 | -5.86 | 0.63 | -0.81 | 1.57 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -11.17 | -25.74 | -102.39 | 25.60 | -32.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -11.17 | -25.74 | -102.39 | 25.60 | -32.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 192.24 | 190.93 | 189.14 | 189.74 | 189.05 |
Diluted EPS Before Non-Recurring Items | -0.05 | -0.02 | -0.05 | -0.02 | -0.06 |
Diluted Net EPS (GAAP) | -0.06 | -0.13 | -0.54 | 0.13 | -0.17 |